The role of preeclampsia in breast cancer risk: insights from Mendelian randomization study

被引:0
|
作者
Qian, Chenfei [1 ]
Xiong, Ganwei [2 ]
Hong, Shihao [3 ]
Miao, Linzhe [1 ]
Guo, Yitao [1 ,4 ]
机构
[1] Zhejiang Hosp, Hangzhou 310013, Peoples R China
[2] First Peoples Hosp Xiushui Cty, Jiujiang 332400, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Obstet & Gynecol, Hangzhou 310016, Peoples R China
[4] Zhejiang Hosp, Dept Cardiol, Hangzhou 310013, Peoples R China
关键词
Preeclampsia; Breast cancer; Genome-wide association study; Mendelian randomization; Meta-analysis; ENDOTHELIAL-GROWTH-FACTOR; VEGF EXPRESSION; PREGNANCY; PATHOPHYSIOLOGY; ASSOCIATION; SERUM;
D O I
10.1007/s12672-025-02248-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The relationship between preeclampsia and breast cancer risk is still debated, with observational studies yielding inconsistent results. This research aims to clarify the causal link between preeclampsia and breast cancer using Mendelian randomization (MR) methods. Methods We utilized genome-wide association study (GWAS) data to identify single nucleotide polymorphisms (SNPs) that are significantly associated with preeclampsia, which served as genetic instruments. A two-sample Mendelian randomization (TSMR) approach was applied, primarily using inverse variance weighting (IVW) to assess the causal impact of preeclampsia on breast cancer risk. To strengthen our findings, a meta-analysis of IVW estimates from both discovery and validation cohorts was performed, complemented by sensitivity analyses to investigate heterogeneity and potential horizontal pleiotropy. Results In the discovery cohort, IVW analysis revealed a potential inverse relationship between preeclampsia and breast cancer risk (OR, 0.971; 95% CI, 0.947-0.996; P = 0.022). However, the validation cohort did not demonstrate a significant causal association (OR, 0.992; 95% CI, 0.975-1.008; P = 0.327). The combined meta-analysis indicated that preeclampsia might be linked to a lower risk of breast cancer (OR, 0.986; 95% CI, 0.972-0.999; P = 0.041). In subgroup analysis, preeclampsia was found to have a potential association only with estrogen receptor (ER)-negative breast cancer (OR, 0.956; 95% CI, 0.916-0.999; P = 0.043), while no significant link was observed with estrogen receptor (ER)-positive breast cancer (OR, 0.972; 95% CI, 0.945-1.000; P = 0.051). Sensitivity analyses indicated no significant heterogeneity or evidence of horizontal pleiotropy (P > 0.05). Conclusion This MR study, supported by a robust meta-analysis, suggests that preeclampsia may have a protective effect against breast cancer, especially ER-negative breast cancer. However, to firmly establish this relationship, additional prospective studies with larger populations are warranted. Moreover, further exploration of the biological mechanisms underlying this potential association is needed through both in vitro and in vivo research.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Insights into Causal Cardiovascular Risk Factors from Mendelian Randomization
    C. M. Schooling
    J. V. Zhao
    Current Cardiology Reports, 2023, 25 : 67 - 76
  • [42] Bone mineral density and risk of breast cancer: A cohort study and Mendelian randomization analysis
    Zhang, Y.
    Mao, X.
    Yu, X.
    Huang, X.
    He, W.
    Yang, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S185 - S185
  • [43] Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization Study
    Dimou, Niki
    Yarmolinsky, James
    Bouras, Emmanouil
    Tsilidis, Konstantinos K.
    Martin, Richard M.
    Lewis, Sarah J.
    Gram, Inger T.
    Bakker, Marije F.
    Brenner, Hermann
    Figueiredo, Jane C.
    Fortner, Renee T.
    Gruber, Stephen B.
    van Guelpen, Bethany
    Hsu, Li
    Kaaks, Rudolf
    Kweon, Sun-Seog
    Lin, Yi
    Lindor, Noralane M.
    Newcomb, Polly A.
    Sanchez, Maria-Jose
    Severi, Gianluca
    Tindle, Hilary A.
    Tumino, Rosario
    Weiderpass, Elisabete
    Gunter, Marc J.
    Murphy, Neil
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (05) : 953 - 964
  • [44] The association between plasma chemokines and breast cancer risk and prognosis: A mendelian randomization study
    Yu, Xingxing
    Zhang, Yanyu
    Lin, Yuxiang
    Zou, Shuqing
    Zhu, Pingxiu
    Song, Mengjie
    Fu, Fangmeng
    Yang, Haomin
    FRONTIERS IN GENETICS, 2023, 13
  • [45] Genetically predicted circulating concentrations of micronutrients and risk of breast cancer: A Mendelian randomization study
    Papadimitriou, Nikos
    Dimou, Niki
    Gill, Dipender
    Tzoulaki, Ioanna
    Murphy, Neil
    Riboli, Elio
    Lewis, Sarah J.
    Martin, Richard M.
    Gunter, Marc J.
    Tsilidis, Konstantinos K.
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (03) : 646 - 653
  • [46] Bone mineral density and risk of breast cancer: A cohort study and Mendelian randomization analysis
    Zhang, Yanyu
    Mao, Xinhe
    Yu, Xingxing
    Huang, Xiaoxi
    He, Wei
    Yang, Haomin
    CANCER, 2022, 128 (14) : 2768 - 2776
  • [47] Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study
    Jiang, Xia
    Dimou, Niki L.
    Al-Dabhani, Kawthar
    Lewis, Sarah J.
    Martin, Richard M.
    Haycock, Philip C.
    Gunter, Marc J.
    Key, Timothy J.
    Eeles, Rosalind A.
    Muir, Kenneth
    Neal, David
    Giles, Graham G.
    Giovannucci, Edward L.
    Stampfer, Meir
    Pierce, Brandon L.
    Schildkraut, Joellen M.
    Andersen, Shaneda Warren
    Thompson, Deborah
    Zheng, Wei
    Kraft, Peter
    Tsilidis, Konstantinos K.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2019, 48 (05) : 1416 - 1424
  • [48] Sex hormones in the risk of breast cancer: a two-sample Mendelian randomization study
    Ke, Bin
    Li, Chunyu
    Shang, Huifang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (03): : 1128 - +
  • [49] Mendelian randomization study identifying immune cell phenotypes associated with breast cancer risk
    Zhang, Zhiqin
    Zhao, Junfeng
    Li, Ying
    Zhang, Huijuan
    Chen, Yunsong
    Yang, Linke
    Zhang, Yanhui
    Li, Yang
    Lin, Jiamao
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [50] Causal relationship between dietary factors and breast cancer risk: A Mendelian randomization study
    Yu, Chengdong
    Xu, Jiawei
    Xu, Siyi
    Peng, Huoping
    Tang, Lei
    Sun, Zhengkui
    Chen, Wen
    HELIYON, 2023, 9 (10)